We first treated HEK293Tcells coexpressing HTN-BRD4 and fOGT with OGTACs for various durations;then, we replaced the culture media and exposed the cells to a rhodamineligand, which fluorescently labeled the HTN-BRD4 that did not interactwith OGTACs (Figure 1C). This evidence concerns the gene BRD4 and hypertensive disorder.